 |
 Previous Article | Next Article 
The Journal of Neuroscience, November 1, 1998, 18(21):9002-9009
Mediodorsal Thalamus Plays a Critical Role in the Development of
Limbic Motor Seizures
Robert M.
Cassidy and
Karen
Gale
Interdisciplinary Program in Neuroscience and Department of
Pharmacology, Georgetown University Medical Center, Washington, DC
20007
 |
ABSTRACT |
Limbic motor seizures in animals, analogous to complex partial
seizures in humans, result in a consistent activation of the mediodorsal thalamus (MD) and, with prolonged seizures, damage to MD.
This study examined the functional role of MD in focally evoked limbic
motor seizures in the rat. GABA- and glutamate (Glu)-mediated synaptic
transmissions in MD were evaluated for an influence on seizures evoked
from area tempestas (AT), a discrete epileptogenic site in the rostral
piriform cortex.
A GABAA receptor agonist, Glu receptor antagonists, or a
GABA-elevating agent were focally microinfused into MD before evoking seizures by focal application of bicuculline methiodide into the ipsilateral AT. Focal pretreatment of MD with the GABAA
agonist muscimol (190 pmol) protected against seizures evoked from AT. Seizure protection was also obtained with the focal application of
2,3-dihydroxy-6-nitro-7-sulfamoyl-benzo(F)quinoxaline (NBQX) (500 pmol), an antagonist of the AMPA subtype of Glu receptors, into MD. In
contrast, focal pretreatment of MD with a competitive antagonist of the
NMDA receptor 2-amino-7-phosphonoheptanoic acid (500 pmol) did not
attenuate seizures. The anticonvulsant effects achieved with intra-MD
injections of muscimol and NBQX were site-specific, because no seizure
protection was obtained with injections placed 2 mm ventral or lateral
to MD. Prolonged seizure protection was obtained following GABA
elevation in MD after the application of the GABA transaminase
inhibitor vigabatrin (194 nmol). These results suggest the following:
(1) MD is a critical participant in the generation of seizures elicited
focally from piriform cortex; (2) transmission via AMPA receptors, but
not NMDA receptors, in MD regulates limbic seizure propagation; and (3)
a GABA-mediated system exists within MD, the enhancement of which
protects against focally evoked limbic motor seizures.
Key words:
area tempestas; piriform cortex; bicuculline; GABA; glutamate; vigabatrin
| |
INTRODUCTION |
Area tempestas (AT) is a
functionally defined, discrete epileptogenic site deep within the
anterior piriform cortex, which has been identified in the rat and
monkey (Piredda and Gale, 1985 ; Gale and Dubach, 1993). In the rat,
unilateral microinjection of picomole amounts of GABA receptor
antagonists or glutamate (Glu) receptor agonists elicits synchronous
bilateral electrographic and motor seizures, characterized by facial
and forelimb clonus with rearing and loss of balance (Piredda and Gale,
1985); this type of seizure, often referred to as "limbic motor
seizure", is analogous to secondarily generalized complex partial
seizures in humans (McNamara et al., 1993). Two neurochemical
substrates within AT are crucial to seizure genesis: inhibitory
GABAergic transmission and excitatory glutamatergic transmission. A
tonic balance between excitatory glutamatergic input and inhibitory GABAergic input exists within AT, and the unilateral disruption of this
balance in favor of excitation triggers seizures. Accordingly, focal
injection of bicuculline, a GABAA receptor antagonist,
removes the endogenous inhibitory control in AT and allows the
endogenous excitatory drive to evoke limbic motor seizures (Piredda and
Gale, 1986a). In the rat, the local blockade of either NMDA or AMPA receptors protects against seizure activity elicited by focal bicuculline, indicating that both subtypes of Glu receptor are necessary for seizure initiation from AT (Piredda and Gale, 1986a; Tortorella et al., 1997).
Studies mapping increases in metabolic activity, as indicated by the
uptake of [14C]2-deoxyglucose (2DG), have found
that seizures evoked from anterior piriform cortex produce a marked
increase in cellular metabolism in a specific set of forebrain regions.
These areas include olfactory bulbs, posterior piriform cortex,
perirhinal cortex, amygdala, entorhinal cortex, and mediodorsal
thalamus (MD) (see Fig. 1) (Gale, 1993; White and Price, 1993).
Similarly, a time course of immunohistochemical localization of heat
shock protein during ictal activity elicited from unilateral injections
of bicuculline into AT demonstrates that this cellular stress marker is
expressed preferentially in the ipsilateral amygdala, posterior
piriform cortex, perirhinal cortex, and MD (Shimosaka et al., 1992).
Interestingly, perirhinal cortex (Tortorella et al., 1997) and
posterior piriform cortex (Halonen et al., 1994) appear to serve as
important relays in the seizure-propagating network, based on the fact
that inhibition within these regions impedes seizure generation. The
anatomical connections of MD suggest that it may represent another
critical component of the limbic seizure network. Because MD receives
input from numerous components of the limbic system, including the
piriform and rhinal cortices, it may integrate input from these
multiple components and link them with cingulate cortex and with
orbitofrontal cortex, with which MD has reciprocal connections
(Russchen et al., 1987; Giguere and Goldman-Rakic, 1988; Gower, 1989;
Carmichael and Price, 1995).
Furthermore, studies analyzing patterns of neurodegeneration after
seizures have reported that pronounced neuronal death occurs bilaterally in MD as a result of continuous generalized seizure activity evoked from AT (Shimosaka et al., 1992), systemic
administration of pilocarpine (Turski et al., 1986), and in humans
experiencing prolonged idiopathic hemiconvulsions (Mori et al., 1992).
These findings raise the possibility that seizure-induced pathology in
MD may contribute to short-term and/or long-term consequences of
prolonged or repeated seizures.
In view of the above evidence that MD is a target of seizure activity
triggered from piriform cortex, we investigated the functional role of
MD in limbic motor seizures. In the present study, we tested the
hypothesis that MD contributes to the propagation of limbic seizures
evoked from the piriform cortex. To accomplish this, we examined the
effects of focal inhibition of MD on seizures evoked from AT.
| |
MATERIALS AND METHODS |
Animals. All experiments were performed on male
Sprague Dawley albino rats (250-350 gm; Harlan Labs, Walkersville,
MD). The animals were housed in groups of three to four per cage under environmentally controlled conditions (12 hr light/dark cycle, lights
on between 8:00 A.M. and 8:00 P.M.; ambient temperature 23° ± 1°C), with food and water provided ad libitum. All
experiments were conducted during the light cycle in awake freely
moving animals and strictly conformed to all guidelines set forth by
the Georgetown University Animal Care and Use Committee.
Surgery. Rats were anesthetized with Equithesin (2.7 ml/kg,
i.p.) and placed in a Kopf stereotaxic apparatus. Two 22-gauge stainless steel guide cannulas (0.71 mm external diameter), one directed at the left AT and one directed at the left MD, were then
stereotaxically implanted and fixed to the skull with dental acrylic
and stainless steel jeweler's screws.
According to the deGroot coordinate system (Pellegrino et al., 1973),
the coordinates used for the final injection sites, with the incisor
bar 5 mm above the interaural line, were as follows: AT, 4 mm anterior
to bregma; 3.5 mm lateral to midline; and 6.5 mm ventral to dura; MD,
1.2 mm posterior to bregma; 1.0 mm lateral to midline; and 6.2 mm
ventral to dura (see Fig. 2A,B for
AT and MD sites, respectively).
Drugs. 2-Amino-7-phosphonoheptanoic acid (AP-7) (Research
Biochemicals, Natick, MA) was dissolved in a small volume (<10% of
final volume) of 1N NaOH, the pH was adjusted to 7.4 with
H3PO4, and the solution was then diluted
with distilled deionized water to a concentration of 0.5 mg/ml. A dose
of 500 pmol of AP-7 was injected in a volume of 225 nl over a duration
of 5 min. Bicuculline methiodide (Sigma, Saint Louis, MO) was dissolved
in saline at a concentration of 0.5 mg/ml; 118 pmol in 120 nl was
infused over 2 min 40 sec. Equithesin (used for anesthetic) was made by
combining chloral hydrate (4.3%), pentobarbital (0.9%), and
MgSO4 (2.1%) in propylene glycol-ethanol-water.
Vigabatrin (Marion Merrel Dow, Cincinatti, OH) was dissolved in saline
at a concentration of 100 mg/ml; 194 nmol in 250 nl was infused over a
duration of 5 min 33 sec. Muscimol (Natural Products Research
Chemicals) was dissolved in saline at a concentration of 0.1 mg/ml; 190 pmol in 240 nl was infused over a period of 5 min 20 sec. The sodium salt 2,3-dihydroxy-6-nitro-7-sulfamoyl-benzo(F)-quinoxaline (NBQX) (NovoNordisk, Malov, Denmark) was dissolved in saline at a
concentration of 1.0 mg/ml; 500 pmol in a volume of 159 nl was infused
over a duration of 3 min 45 sec.
Experimental procedures. After a postoperative recovery
period of at least 48 hr, each animal received a unilateral
microinfusion of a convulsant dose of bicuculline methiodide (118 pmol)
in AT with or without pharmacological pretreatment of MD. Glu receptor antagonists (AP-7 or NBQX), a GABAA receptor agonist
(muscimol), or an irreversible inhibitor of GABA transaminase
(vigabatrin) were focally microinfused in the ipsilateral MD before the
unilateral application of bicuculline to AT. For each infusion, a
28-gauge internal cannula (0.36 mm external diameter) was inserted
through the guide cannula while the rat was gently handheld, and the
drugs were then infused at a rate of 45 nl/min. The internal cannula was connected via polyethylene tubing to a 10 µl Hamilton syringe (Hamilton Co., Reno, NV) driven by a Sage infusion pump. After each
infusion, the internal cannula was left in place for 1 min to ensure
proper delivery of drug solution.
All animals were observed for convulsive activity for at least 2 hr
after the final infusion of bicuculline in AT. Seizure severity was
evaluated using the following scoring system modified from Racine
(1972): 0.5, facial clonus; 1, myoclonus of the contralateral forelimb;
2, bilateral forelimb clonus (with or without facial and jaw
clonus) lasting <15 sec; 3, bilateral forelimb clonus lasting
>15 sec; 4, rearing in addition to bilateral forelimb clonus; 5, rearing and loss of balance in addition to bilateral forelimb
clonus.
Histology. Brains were sectioned (50 µm) on a
freezing-stage microtome. Injection sites were then verified in cresyl
violet-stained sections viewed under light microscopy. Rats in which
cannula placements were not within AT were excluded from analysis. The locations of intrathalamic injection sites are shown in Figure 2B.
Evaluation of seizure response. Seizure analysis was
conducted according to three parameters: seizure incidence, seizure
severity, and seizure frequency. Seizure incidence is defined as the
percentage of animals that exhibit bilateral clonic seizures in an
experimental treatment group. Seizure severity is defined as the mean
of the maximum seizure scores attained by the animals in a group.
Seizure frequency is the number of clonic seizure episodes (score of 3, 4, or 5) occurring within 2 hr of the injection of bicuculline into AT.
A two-tailed t test or a repeated-measures ANOVA was used
for statistical evaluation of seizure frequency; comparisons were made
between each experimental treatment group and its corresponding control
group.
| |
RESULTS |
Figure 1 shows the autoradiographic
localization of 2DG in coronal sections through the brain of a
representative rat exhibiting recurrent limbic motor seizures (scores 4 and 5) in response to the microinjection of bicuculline methiodide (118 pmol) into AT. In Figure 1, the injection site can be seen in the
left column, middle row
(arrow). Several regions (including frontal, piriform, and
rhinal cortices) in the hemisphere ipsilateral to the injection exhibit
clear hypermetabolism, as evidenced by the high density of 2DG
accumulation. Most regions in the contralateral hemisphere were not
distinguishable from control rats (without seizures), with the
exception of MD, other midline thalamic nuclei, and substantia nigra,
all of which showed marked increases in accumulation of 2DG in both
hemispheres.
View larger version (135K):
[in this window]
[in a new window]
|
Figure 1.
Pictures of autoradiographs showing accumulation
of 2DG (dark areas) in coronal sections of rat brain.
Bicuculline methiodide was injected 15 min before the intraperitoneal
injection of 2DG (18 mCi into 250 gm rats). Rats were anesthetized and
perfused 1 hr after injection of bicuculline. Arrow in
left column, middle row, points to AT
microinfusion site. Arrow in left column,
bottom row, points to MD.
|
|
In control conditions (vehicle in MD), the seizures evoked by the
application of bicuculline methiodide (118 pmol in AT) consisted of
facial and forelimb clonus with rearing (and sometimes loss of balance)
in all animals (scores 4 and 5). Figure 2
shows the location of the injection sites. The AMPA receptor antagonist NBQX (500 pmol; n = 9), when unilaterally microinfused
into MD, protected 100% of the rats against seizures elicited from AT
(Fig. 3). Of the nine animals tested with
NBQX in MD, four animals exhibited no signs of seizure-related
activity, whereas the remaining animals exhibited only brief facial
twitching (four animals) or myoclonic jerks (one animal). Unilateral
focal microinfusion of the NMDA receptor antagonist AP-7 (500 pmol;
n = 7) into MD did not significantly alter the seizure
response evoked from AT (Fig. 4).
View larger version (35K):
[in this window]
[in a new window]
|
Figure 2.
Sites of focal microinfusions. A,
Coronal representation depicting area of microinfusions within AT
(shaded area). B, Drawings of coronal
sections depicting location of microinfusions of muscimol or NBQX
within MD from which seizure protection was obtained
(filled circles). Open circles
represent sites where no seizure protection was obtained from these two
drugs. Numbers indicate anteroposterior distance
from bregma in millimeters.
|
|
View larger version (36K):
[in this window]
[in a new window]
|
Figure 3.
Effect of focal microinfusion of an AMPA receptor
antagonist in MD. NBQX (500 pmol; n = 9) was
unilaterally microinfused into MD 5 min before microinfusion of
bicuculline (118 pmol) into the ipsilateral AT. Difference from
controls, *p < 0.05 (t test).
|
|
View larger version (23K):
[in this window]
[in a new window]
|
Figure 4.
Effect of injection of an NMDA receptor antagonist
in MD. AP-7 (500 pmol; n = 7) was unilaterally
microinfused into MD 5 min before microinfusion of bicuculline (118 pmol) into the ipsilateral AT. Neither seizure severity nor seizure
frequency was modified by AP-7 in MD.
|
|
In view of the distinct effects obtained with NBQX and AP-7, some of
the animals that received NBQX were subsequently tested with AP-7 (at
least 24 hr later), whereas other animals first tested with AP-7 were
later tested with NBQX. We found that in the same rats, with
application of drugs into the same site on separate occasions, the
treatment with NBQX consistently protected against seizures, whereas
the AP-7 treatments were without effect.
Unilateral pretreatment of MD with the GABAA receptor
agonist muscimol (190 pmol; n = 10) 5 min before the
injection of bicuculline in the ipsilateral AT suppressed the
development of limbic seizure activity in 8 of 10 animals. This
anticonvulsant effect was evidenced by a significant reduction in
seizure severity (for protected animals, the mean seizure score was
0.56 compared with 4.5 in the controls; 38% of these animals exhibited
no seizure-related activity), as well as seizure frequency compared
with controls (Fig. 5).
View larger version (43K):
[in this window]
[in a new window]
|
Figure 5.
Effect of focal injection of GABAA
receptor agonist in MD. Muscimol (190 pmol; n = 10)
was microinjected into MD 5 min before microinjection of bicuculline
(118 pmol) into the ipsilateral AT. Difference from controls,
*p < 0.05 (t test).
|
|
The anticonvulsant effects achieved with muscimol and NBQX were
strictly site specific, because no seizure protection was obtained in
six rats with injections placed 1-2 mm ventral or lateral to MD (for
locations, see Fig. 2B). Additionally, different injection sites within MD appeared to be equivalent for achieving seizure protection (data not shown). The focal pretreatment of MD alone
with the drugs tested did not induce changes in posture, spontaneous
behavior, or any other observable abnormalities.
To investigate the role of endogenous GABAergic transmission within MD
for controlling limbic motor seizures, vigabatrin (194 nmol) was
unilaterally microinfused into MD to elevate endogenous GABA locally by
irreversibly inhibiting GABA transaminase activity (Gale and Iadarola,
1980; Casu and Gale, 1981). To evaluate anticonvulsant effects,
bicuculline was applied to AT 2.5, 24, and 48 hr after the vigabatrin
pretreatment.
Pretreatment of MD with a single dose of vigabatrin resulted in
significant seizure protection when rats were tested at 2.5 and 24 hr
after microinfusion of vigabatrin into MD; recovery from the
anticonvulsant effects began by 48 hr, as indicated by seizure
frequency (Fig. 6A) and
the percentage of rats exhibiting seizures at the various time points
tested (Fig. 6B).
View larger version (26K):
[in this window]
[in a new window]
|
Figure 6.
Effect of focal application of a GABA transaminase
inhibitor into MD. Vigabatrin (194 nmol) was unilaterally microinfused
into MD 2.5, 24, or 48 hr before microinfusion of bicuculline into the
ipsilateral AT. Seizure frequency (A) is shown as
mean ± SE for four to six animals per group. Statistical
comparisons using ANOVA were performed on the seizure frequency data
shown in A. Difference from controls,
*p < 0.05. Seizure incidence (percent of rats
exhibiting bilateral clonic seizures) is shown in B for
the same animals analyzed in A.
|
|
| |
DISCUSSION |
The results of this study demonstrate that the focal pretreatment
of MD with a GABAA receptor agonist or a Glu receptor
antagonist interferes with the development of focally evoked limbic
motor seizures. These findings suggest that excitatory transmission within MD is required for the development of limbic seizures and that
this crucial excitatory transmission is primarily glutamatergic. Moreover, the anticonvulsant effects obtained from MD were site specific, because injections placed 1-2 mm lateral or ventral to MD
did not attenuate seizure activity.
In contrast to the effects of the AMPA receptor antagonist NBQX, the
NMDA receptor antagonist AP-7 in MD had no effect on seizure activity.
This finding suggests that AMPA receptors within MD play a more
critical role than NMDA receptors in the transmission involved in the
genesis of limbic seizures elicited from piriform cortex.
Patel et al. (1988) reported that the bilateral focal injection of AP-7
into MD, at doses of 10-50 pmol, significantly protected against
seizures induced by the systemic administration of pilocarpine, a
muscarinic agonist. This finding is in contrast to our results with
AP-7 in MD. The differences between the outcomes of the two studies may
be a result of differences in the seizure models used and/or the
different rat strains used (i.e., Sprague Dawley vs Wistar).
Differences between these two rat strains in functional response to
subtype-specific Glu agonists have been noted previously (Maggio et
al., 1990).
The nonessential role of NMDA receptors in MD for development of
AT-evoked seizures stands in contrast to the role of NMDA receptors in
AT in the rat. Focal microinfusion of AP-7 (100 pmol  1.0 nmol)
into AT before the microinfusion of bicuculline, carbachol, or kainate
was found to prevent the initiation of convulsions from AT (Piredda and
Gale, 1986b), indicating that NMDA receptor-mediated transmission in AT
is required for triggering seizures from this site in the rat. Thus,
the profile of critical neurochemical substrates within AT differs from
that in MD.
On the other hand, the pharmacological profile that we have described
for MD is similar to that described previously for the posterior
piriform cortex, another site critical for the relay of AT-evoked
seizures. The posterior piriform cortex is an important target of
excitatory output from AT and a key component of the network
responsible for the initiation and propagation of seizure activity
generated from this site. In posterior piriform cortex, as in MD,
blockade of AMPA receptors (with NBQX), but not NMDA receptors (with
AP-7), prevents the development of seizures evoked from AT (Halonen et
al., 1994).
Anatomical tracing studies have shown that MD is richly connected to
several structures that may constitute a network for the propagation of
limbic motor seizures elicited from AT. MD receives direct afferents
from AT itself (Sahibzada et al., 1992) and from three primary target
regions of AT: piriform cortex, entorhinal cortex, and perirhinal
cortex (Russchen et al., 1987; Steriade et al., 1987; Gower, 1989;
Kuroda et al., 1992). Perirhinal cortex, like MD, is a crucial relay
for AT-evoked seizures (Tortorella et al., 1997), raising the
possibility that perirhinal cortex and MD may be part of a core
seizure-propagating loop activated by AT. Alternatively, MD may
regulate multiple neural loops and coordinate their coactivation in
parallel. Considerable excitatory connections also exist between MD and
basolateral amygdala (Van Vulpen and Verwer, 1989), and this circuitry
may contribute to the unusually rapid transfer of kindling between AT
and amygdala (McIntyre and Goddard, 1973).
In addition to its associations with limbic structures, MD is linked
directly and indirectly (e.g., via prefrontal cortex) with basal
ganglia structures that regulate the threshold for limbic motor
seizures. Such structures include substantia nigra and entopeduncular
nucleus (Kuroda and Price, 1991), which when inhibited bilaterally
exert anticonvulsant actions in several seizure models (Gale, 1992),
and striatum, which suppresses seizures when disinhibited or stimulated
(Cavalheiro et al., 1987; Turski et al., 1987). Activation of
corticostriatal projections, which in turn stimulate striatal GABAergic
projections to substantia nigra, could mediate the influence of MD on
seizure susceptibility. However, the fact that we blocked AT seizures
with unilateral inhibition of MD argues against this possibility,
because the unilateral inhibition of substantia nigra is not sufficient
to attenuate AT-evoked seizures (Maggio and Gale, 1989).
The limbic network by which MD influences seizure propagation may share
certain crucial components with the network that supports long-term
recognition memory. MD, perirhinal cortex, and orbitofrontal cortex
have been shown to be critical substrates of recognition memory, based
on recording studies (Fahy et al., 1993a,b; Miller and Desimone, 1994)
and on the observations that selective bilateral lesions of each of
these areas result in profound memory impairment in experimental
animals (Aggleton and Mishkin, 1983; Zola-Morgan and Squire, 1985;
Bachevalier and Mishkin, 1986; Meunier et al., 1993; Suzuki et al.,
1993; Mumby and Pinel, 1994). Furthermore, seizure-induced damage to MD
has been correlated with deficits in radial arm maze learning
(Persinger et al., 1994). In view of the projections from perirhinal
cortex to MD and the reciprocal connections between MD and
orbitofrontal cortex, it is likely that MD serves to link these
circuits into a coordinated network subserving recognition memory. MD
may similarly serve to link the neural loops subserving seizure
propagation in frontolimbic networks. Via its connections with amygdala
and its ability to regulate prefrontal neurons that project to
piriform, perirhinal, and entorhinal cortices, MD may control the
extent to which the activity in the network becomes synchronized.
Hypersynchrony in this network, as occurs with propagated seizures,
would be expected to be incompatible with the more controlled neural
signaling important for encoding memory (Fahy et al., 1993a,b).
Moreover, suppression of this network, as may occur during postictal or
interictal periods, could also impede the mnemonic function of this
circuitry. Thus, seizure-evoked acute and/or chronic alterations in MD
circuitry may contribute to the memory impairment associated with
complex partial seizures.
| |
FOOTNOTES |
Received June 9, 1998; revised Aug. 5, 1998; accepted Aug. 7, 1998.
This work was supported by National Institutes of Health Grants
T32HD07549, NS28130, and NS20576. We thank Dr. Francesco Fornai and
David Dybdal for helpful discussions throughout the course of these
studies and Laura Williams for help with the preparation of this
manuscript.
Correspondence should be addressed to Dr. Karen Gale, Department of
Pharmacology, Georgetown University Medical Center, 3900 Reservoir Road
N.W., Washington, DC 20007.
| |
REFERENCES |
-
Aggleton JP,
Mishkin M
(1983)
Memory impairments following restricted medial thalamus lesions in monkeys.
Exp Brain Res
52:199-209[Web of Science][Medline].
-
Bachevalier J,
Mishkin M
(1986)
Visual recognition memory impairment follows ventromedial but not dorsolateral prefrontal lesions in monkeys.
Behav Brain Res
20:249-261[Web of Science][Medline].
-
Carmichael ST,
Price JL
(1995)
Limbic connections of the orbital and medial prefrontal cortex in macaque monkeys.
J Comp Neurol
363:615-641[Web of Science][Medline].
-
Casu M,
Gale K
(1981)
Intracerebral injection of gamma vinyl GABA: method for measuring rates of GABA synthesis in specific brain regions in vivo.
Life Sci
29:681-688[Web of Science][Medline].
-
Cavalheiro EA,
Bortolotto ZA,
Turski L
(1987)
Microinjections of the
 -aminobutyrate antagonist, bicuculline methiodide, into the caudate-putamen prevent amygdala-kindled seizures in rats.
Brain Res
411:370-372[Medline]. -
Fahy FL,
Riches IP,
Brown MN
(1993a)
Neuronal signals of importance to the performance of visual recognition memory tasks: evidence from recordings of single neurones in the medial thalamus of primates.
Prog Brain Res
95:401-416[Web of Science][Medline].
-
Fahy FL,
Riches IP,
Brown MN
(1993b)
Neuronal activity related to visual recognition memory: long-term memory and the encoding of recency and familiarity information in the primate anterior and medial inferior temporal and rhinal cortex.
Exp Brain Res
96:457-472[Web of Science][Medline].
-
Gale K
(1992)
Subcortical structures and pathways involved in convulsive seizure generation.
J Clin Neurophysiol
9:264-277[Web of Science][Medline].
-
Gale K
(1993)
Focal trigger zones and pathways of propagation in seizure generation.
In: Epilepsy: models, mechanisms, and concepts (Schwartzkroin PA,
ed), pp 48-93. Cambridge, UK: Cambridge UP.
-
Gale K,
Dubach M
(1993)
Localization of area tempestas in the piriform cortex of the monkey.
Soc Neurosci Abstr
19:21.
-
Gale K,
Iadarola MJ
(1980)
Seizure protection and increased nerve-terminal GABA: delayed effects of GABA transaminase inhibition.
Science
208:288-291[Abstract/Free Full Text].
-
Giguere M,
Goldman-Rakic PS
(1988)
Mediodorsal nucleus: areal, laminar and tangential distribution of afferents and efferents in the frontal lobe of rhesus monkeys.
J Comp Neurol
277:195-213[Web of Science][Medline].
-
Gower EC
(1989)
Efferent projections from limbic cortex of the temporal pole to the magnocellular medial dorsal nucleus in the rhesus monkey.
J Comp Neurol
280:343-358[Web of Science][Medline].
-
Halonen T,
Tortorella A,
Zrebeet H,
Gale K
(1994)
Posterior piriform cortex and perirhinal cortex relay seizures evoked from the area tempestas: role of excitatory and inhibitory amino acid receptors.
Brain Res
652:145-148[Web of Science][Medline].
-
Kuroda M,
Price JL
(1991)
Ultrastructure and synaptic organization of axon terminals from brainstem structures to the mediodorsal nucleus of the rat.
J Comp Neurol
313:539-552[Web of Science][Medline].
-
Kuroda M,
Murakami K,
Kishi K,
Price JL
(1992)
Distribution of the piriform cortical terminals to cells in the central segment of the mediodorsal thalamic nucleus of the rat.
Brain Res
595:159-163[Medline].
-
Maggio R,
Gale K
(1989)
Seizures evoked from area tempestas are subject to control by GABA and glutamate receptors in substantia nigra.
Exp Neurol
105:184-187[Web of Science][Medline].
-
Maggio R,
Liminga U,
Gale K
(1990)
Selective stimulation of kainate but not quisqualate or NMDA receptors in substantia nigra evokes limbic motor seizures.
Brain Res
528:223-230[Medline].
-
McIntyre DC,
Goddard GV
(1973)
Transfer, interference and spontaneous recovery of convulsions kindled from the rat amygdala.
Electroencephalogr Clin Neurophysiol
35:533-543[Medline].
-
McNamara JO,
Bonhaus DW,
Shin C
(1993)
In: In: Epilepsy: models, mechanisms, and concepts (Schwartzkroin PA, ed), pp 27-47. Cambridge, UK: Cambridge UP.
-
Meunier M,
Bachevalier J,
Mishkin M,
Murray EA
(1993)
Effects on visual recognition of combined and separate ablations of the entorhinal and perirhinal cortex in rhesus monkeys.
J Neurosci
13:5418-5432[Abstract].
-
Miller EK,
Desimone R
(1994)
Parallel neuronal mechanisms for short-term memory.
Science
263:520-522[Abstract/Free Full Text].
-
Mori H,
Mizutani T,
Yoshimura M,
Yamanouchi H,
Shimada H
(1992)
Unilateral brain damage after prolonged hemiconvulsions in the elderly associated with theophylline administration.
J Neurol Neurosurg Psychiatry
55:466-469[Abstract/Free Full Text].
-
Mumby DG,
Pinel JPJ
(1994)
Rhinal cortex lesions and object recognition in rats.
Behav Neurosci
108:11-18[Web of Science][Medline].
-
Patel S,
Millan MH,
Meldrum BS
(1988)
Decrease in excitatory transmission within the lateral habenula and the mediodorsal thalamus protects against limbic seizures in rats.
Exp Neurol
101:63-74[Web of Science][Medline].
-
Pellegrino LJ,
Pellegrino AS,
Cushman AJ
(1973)
In: A stereotaxic atlas of the rat brain. New York: Plenum.
-
Persinger M,
Bureau Y,
Peredery O
(1994)
Dissociation between conditioned taste aversion and radial arm maze learning following seizure-induced multifocal brain damage: quantitative tests of serial vs. parallel circuit models of memory.
Physiol Behav
56:225-235[Medline].
-
Piredda S,
Gale K
(1985)
A crucial epileptogenic site in the deep prepiriform cortex.
Nature
317:623-625[Medline].
-
Piredda S,
Gale K
(1986a)
Role of excitatory amino acid transmission in the genesis of seizures elicited from the deep prepiriform cortex.
Brain Res
377:205-210[Web of Science][Medline].
-
Piredda S,
Gale K
(1986b)
Anticonvulsant action of 2-amino-7-phosphonoheptanoic acid and muscimol in the deep prepiriform cortex.
Eur J Pharmacol
120:115-118[Medline].
-
Racine RJ
(1972)
Modification of seizure activity by electrical stimulation. II. Motor seizure.
Electroencephalogr Clin Neurophysiol
32:281-294[Web of Science][Medline].
-
Russchen FT,
Amaral DG,
Price JL
(1987)
The afferent input to the magnocellular division of the mediodorsal thalamic nucleus in the monkey, Macaca fascicularis.
J Comp Neurol
256:175-210[Web of Science][Medline].
-
Sahibzada N,
Chen W,
Halonen T,
Gale K
(1992)
Anatomical connections of the area tempestas in the rat.
Soc Neurosci Abstr
17:509.
-
Shimosaka S,
So YT,
Simon RP
(1992)
Distribution of HSP72 induction and neuronal death following limbic seizures.
Neurosci Lett
138:202-206[Web of Science][Medline].
-
Steriade M,
Parent A,
Pare D,
Smith Y
(1987)
Cholinergic and non-cholinergic neurons of cat basal forebrain project to reticular and mediodorsal thalamic nuclei.
Brain Res
408:372-376[Web of Science][Medline].
-
Suzuki WA,
Zola-Morgan S,
Squire LR,
Amaral DG
(1993)
Lesions of the perirhinal and parahippocampal cortices in the monkey produce long-lasting memory impairment in visual and tactual modalities.
J Neurosci
13:2430-2451[Abstract].
-
Tortorella A,
Halonen T,
Sahibzada N,
Gale K
(1997)
A crucial role of the
 -amino-3-hydroxy-5-methylisoxazole-4-propionic acid subtype of glutamate receptors in piriform and perirhinal cortex for the initiation and propagation of limbic motor seizures.
J Pharmacol Exper Ther
280:1401-1405[Abstract/Free Full Text]. -
Turski L,
Cavalheiro EA,
Sieklucka-Dziuba M,
Ikonomidou-Turski C,
Czuczwar SJ,
Turski WA
(1986)
Seizures produced by pilocarpine: neuropathological sequelae and activity of glutamate decarboxylase in the rat forebrain.
Brain Res
398:37-48[Web of Science][Medline].
-
Turski L,
Meldrum BS,
Cavalheiro EA,
Calderazzo-Filho LS,
Bortolotto ZA,
Ikonomidou-Turski C,
Turski WA
(1987)
Paradoxical anticonvulsant activity of the excitatory amino acid N-methyl-D-aspartate in the rat caudate-putamen.
Proc Natl Acad Sci USA
84:1689-1693[Abstract/Free Full Text].
-
Van Vulpen EHS,
Verwer RWH
(1989)
Organization of projections from the mediodorsal nucleus of the thalamus to the basolateral complex of the amygdala in the rat.
Brain Res
500:389-394[Medline].
-
White LE,
Price JL
(1993)
The functional anatomy of limbic status epilepticus in the rat. I. Patterns of [14C]2-deoxyglucose uptake and Fos immunocytochemistry.
J Neurosci
13:4787-4809[Abstract].
-
Zola-Morgan S,
Squire LR
(1985)
Amnesia in monkeys after lesions of the mediodorsal nucleus of the thalamus.
Ann Neurol
17:558-564[Web of Science][Medline].
Copyright © 1998 Society for Neuroscience 0270-6474/98/18219002-08$05.00/0
This article has been cited by other articles:
|
|
|
|
 
A. Labate, A. Cerasa, A. Gambardella, U. Aguglia, and A. Quattrone
Hippocampal and thalamic atrophy in mild temporal lobe epilepsy: A VBM study
Neurology,
September 30, 2008;
71(14):
1094 - 1101.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
K. Rajasekaran, J. Kapur, and E. H. Bertram
Alterations in GABAA Receptor Mediated Inhibition in Adjacent Dorsal Midline Thalamic Nuclei in a Rat Model of Chronic Limbic Epilepsy
J Neurophysiol,
November 1, 2007;
98(5):
2501 - 2508.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
M. Guye, J. Regis, M. Tamura, F. Wendling, A. M. Gonigal, P. Chauvel, and F. Bartolomei
The role of corticothalamic coupling in human temporal lobe epilepsy
Brain,
July 1, 2006;
129(7):
1917 - 1928.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
S.-I. Ito and A. D. Craig
Vagal-Evoked Activity in the Parafascicular Nucleus of the Primate Thalamus
J Neurophysiol,
October 1, 2005;
94(4):
2976 - 2982.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
H. Blumenfeld, K. A. McNally, S. D. Vanderhill, A. L. Paige, R. Chung, K. Davis, A. D. Norden, R. Stokking, C. Studholme, E. J. Novotny Jr, et al.
Positive and Negative Network Correlations in Temporal Lobe Epilepsy
Cereb Cortex,
August 1, 2004;
14(8):
892 - 902.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
D. X. Zhang and E. H. Bertram
Different Reactions of Control and Epileptic Rats to Administration of APV or Muscimol on Thalamic or CA3-Induced CA1 Responses
J Neurophysiol,
November 1, 2003;
90(5):
2875 - 2883.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
H. Blumenfeld and J. Taylor
Why do Seizures Cause Loss of Consciousness?
Neuroscientist,
October 1, 2003;
9(5):
301 - 310.
[Abstract]
[PDF]
|
|
|
|
|
|
|
J. Natsume, N. Bernasconi, F. Andermann, and A. Bernasconi
MRI volumetry of the thalamus in temporal, extratemporal, and idiopathic generalized epilepsy
Neurology,
April 22, 2003;
60(8):
1296 - 1300.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
D. X. Zhang and E. H. Bertram
Midline Thalamic Region: Widespread Excitatory Input to the Entorhinal Cortex and Amygdala
J. Neurosci.,
April 15, 2002;
22(8):
3277 - 3284.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
H. Kubova, R. Druga, K. Lukasiuk, L. Suchomelova, R. Haugvicova, I. Jirmanova, and A. Pitkanen
Status Epilepticus Causes Necrotic Damage in the Mediodorsal Nucleus of the Thalamus in Immature Rats
J. Neurosci.,
May 15, 2001;
21(10):
3593 - 3599.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
Top
Abstract
Introduction
Compound via MeSH
